Ilumya Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Tildrakizumab

Indications/Uses

Adults w/ moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Dosage/Direction for Use

SC Recommended dose: 100 mg at wk 0, 4 & every 12 wk thereafter.

Contraindications

Hypersensitivity.

MIMS Class

Immunosuppressants

ATC Classification

L04AC17 - tildrakizumab ; Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Regulatory Classification

POM

Presentation/Packing

Form

Ilumya soln for inj 100 mg/mL

Packing/Price

1's

Ilumya

tildrakizumab

Manufacturer:

Vetter Pharma